Mystic Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Mystic Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.29M	Sell	21,275 -33	-0.2%	-$1.92K	0.3%	87
2025 Q4	$1.15M	Sell	21,308 -3,350	-14%	-$161K	0.26%	90
2025 Q3	$1.11M	Buy	24,658 +566	+2%	+$26.4K	0.25%	93
2025 Q2	$1.12M	Buy	24,092 +634	+3%	+$31.1K	0.27%	90
2025 Q1	$1.43M	Sell	23,458 -500	-2%	-$29.1K	0.38%	74
2024 Q4	$1.36M	Buy	23,958 +9,206	+62%	+$514K	0.36%	72
2024 Q3	$763K	Sell	14,752 -67	-0.5%	-$3.14K	0.29%	87
2024 Q2	$615K	Sell	14,819 -1,471	-9%	-$65.8K	0.25%	96
2024 Q1	$883K	Buy	16,290 +220	+1%	+$11.2K	0.37%	79
2023 Q4	$825K	Buy	16,070 +394	+3%	+$20.7K	0.39%	78
2023 Q3	$910K	Sell	15,676 -409	-3%	-$25.1K	0.51%	69
2023 Q2	$1.03M	Sell	16,085 -350	-2%	-$23.5K	0.55%	64
2023 Q1	$1.14M	Sell	16,435 -199	-1%	-$14K	0.63%	57
2022 Q4	$1.2M	Hold	16,634	–	–	0.68%	52
2022 Q3	$1.18M	Buy	16,634 +150	+0.9%	+$10.9K	0.76%	47
2022 Q2	$1.27M	Buy	16,484 +1,135	+7%	+$86.4K	0.77%	47
2022 Q1	$1.12M	Sell	15,349 -1,010	-6%	-$67.8K	0.6%	57
2021 Q4	$1.02M	Buy	+16,359	New	+$960K	0.48%	65

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mystic Asset Management's BMY Position: Q1 2026 in Review

Mystic Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.15% in Q1 2026, selling an estimated $1.92K and leaving 21,275 shares worth $1.29M. The position accounts for 0.3% of the portfolio, ranked #87.

Mystic Asset Management first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.43M in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Mystic Asset Management held 21,275 shares of Bristol-Myers Squibb worth $1.29M as of Q1 2026.
Mystic Asset Management sold 33 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.92K.
Bristol-Myers Squibb made up 0.3% of Mystic Asset Management's portfolio in Q1 2026, its #87 holding.
Mystic Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
Mystic Asset Management's Bristol-Myers Squibb position peaked at $1.43M in Q1 2025.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mystic Asset Management's 13F filing for Q1 2026, filed 8 May 2026.